法国赛诺菲的喜保宁一盒多少粒？

France's Sanofi's generic name is vigabatrin, and its brand name is Sabril. It is an effective drug for partial seizures, generalized seizures, infantile spasms, and Landau-Kleffner syndrome. Currently, France's Sanofi's Vigabatrin has not been approved for marketing in China. Vigabatrin has an anti-epileptic effect and has a certain auxiliary therapeutic effect in the treatment of epilepsy. It is especially useful for patients who have failed to respond to other anti-epileptic drugs or for patients with partial seizures and infantile spasms. When used alone, it has a good effect on newly diagnosed patients, but it should not be used by pregnant or lactating women, and it should also be used with caution by the elderly or patients with renal damage.

The recommended dosage of France's Sanofi's Vigabatrin is 2g per day, taken in divided doses. The dose should be increased according to the clinical effect at a rate of 0.5-1g per day to the maximum daily dose of 4g (or 50mg/kg per day), which is effective for complex partial seizures of epilepsy (with or without generalized tonic-clonic seizures). Children: - General usage: For children aged 3-9 years, the recommended dose is 1g per day, taken in 2 times; for older children, 2g per day, taken in 2 times.

So how many pills does a box of French Sanofi's Vigabatrin take? According to Medical Companion Travel, the specifications of French Sanofi (vigabatrin) are 500 mg x 100 capsules per box. If you need to obtain purchase information of this drug, please consult Medical Companion Travel Service.

Recommended related hot articles: /newsDetail/95630.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.